[Form 4] Auburn National Bancorporation Insider Trading Activity
David E. Housel, a director of Auburn National Bancorporation (AUBN), reported a purchase of 100 shares of common stock on 09/09/2025 at a price of $27.19 per share. After the transaction he beneficially owns 8,631 shares. The Form 4 reflects a direct acquisition and is signed by the reporting person.
David E. Housel, membro del consiglio di Auburn National Bancorporation (AUBN), ha segnalato l'acquisto di 100 azioni ordinarie il 09/09/2025 al prezzo di $27.19 per azione. Dopo l'operazione detiene beneficiariamente 8,631 azioni. Il Modulo 4 indica un'acquisto diretto ed è firmato dalla persona che ha effettuato la comunicazione.
David E. Housel, director de Auburn National Bancorporation (AUBN), informó la compra de 100 acciones ordinarias el 09/09/2025 a un precio de $27.19 por acción. Tras la operación posee beneficiariamente 8,631 acciones. El Formulario 4 refleja una adquisición directa y está firmado por la persona que reporta.
David E. Housel은 Auburn National Bancorporation(AUBN)의 이사로서 2025-09-09에 보통주 100주를 주당 $27.19에 매수했다고 신고했습니다. 해당 거래 후 그는 이익귀속 방식으로 8,631주를 보유하고 있습니다. Form 4에는 직접 취득으로 기재되어 있으며, 신고인이 서명했습니다.
David E. Housel, administrateur d'Auburn National Bancorporation (AUBN), a déclaré l'achat de 100 actions ordinaires le 09/09/2025 au prix de $27.19 par action. Après la transaction, il détient à titre bénéficiaire 8,631 actions. Le formulaire 4 indique une acquisition directe et est signé par la personne déclarant.
David E. Housel, Direktor von Auburn National Bancorporation (AUBN), meldete den Kauf von 100 Stammaktien am 09.09.2025 zum Preis von $27.19 je Aktie. Nach der Transaktion besitzt er wirtschaftlich 8,631 Aktien. Das Formular 4 verzeichnet einen direkten Erwerb und ist vom meldenden Personen unterschrieben.
- None.
- None.
Insights
TL;DR: Insider purchased a small number of shares; ownership remains modest relative to typical institutional stakes.
The Form 4 shows a direct purchase of 100 AUBN shares at $27.19, bringing the director's total to 8,631 shares. This is a routine disclosure under Section 16 and does not indicate a material change to ownership or control. The trade size is small relative to typical market-moving insider transactions and is unlikely to materially affect valuation or liquidity.
TL;DR: Routine insider purchase disclosure; compliance with Section 16 filing requirements.
The filing documents a timely, signed Form 4 reporting by a director, indicating compliance with reporting obligations. The transaction was reported as a direct acquisition and includes the required signature. There are no derivative transactions or other governance-related actions disclosed in this form.
David E. Housel, membro del consiglio di Auburn National Bancorporation (AUBN), ha segnalato l'acquisto di 100 azioni ordinarie il 09/09/2025 al prezzo di $27.19 per azione. Dopo l'operazione detiene beneficiariamente 8,631 azioni. Il Modulo 4 indica un'acquisto diretto ed è firmato dalla persona che ha effettuato la comunicazione.
David E. Housel, director de Auburn National Bancorporation (AUBN), informó la compra de 100 acciones ordinarias el 09/09/2025 a un precio de $27.19 por acción. Tras la operación posee beneficiariamente 8,631 acciones. El Formulario 4 refleja una adquisición directa y está firmado por la persona que reporta.
David E. Housel은 Auburn National Bancorporation(AUBN)의 이사로서 2025-09-09에 보통주 100주를 주당 $27.19에 매수했다고 신고했습니다. 해당 거래 후 그는 이익귀속 방식으로 8,631주를 보유하고 있습니다. Form 4에는 직접 취득으로 기재되어 있으며, 신고인이 서명했습니다.
David E. Housel, administrateur d'Auburn National Bancorporation (AUBN), a déclaré l'achat de 100 actions ordinaires le 09/09/2025 au prix de $27.19 par action. Après la transaction, il détient à titre bénéficiaire 8,631 actions. Le formulaire 4 indique une acquisition directe et est signé par la personne déclarant.
David E. Housel, Direktor von Auburn National Bancorporation (AUBN), meldete den Kauf von 100 Stammaktien am 09.09.2025 zum Preis von $27.19 je Aktie. Nach der Transaktion besitzt er wirtschaftlich 8,631 Aktien. Das Formular 4 verzeichnet einen direkten Erwerb und ist vom meldenden Personen unterschrieben.